| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.579 | 13.492 | 20.138 | 24.640 | 23.024 | 28.846 | 34.296 | 43.713 | 53.123 |
| Total Income - EUR | - | 8.579 | 13.492 | 20.138 | 24.640 | 23.024 | 28.846 | 34.296 | 43.713 | 53.123 |
| Total Expenses - EUR | - | 7.750 | 12.417 | 11.055 | 4.922 | 4.364 | 6.457 | 4.500 | 22.622 | 25.249 |
| Gross Profit/Loss - EUR | - | 829 | 1.075 | 9.083 | 19.718 | 18.661 | 22.390 | 29.796 | 21.091 | 27.875 |
| Net Profit/Loss - EUR | - | 572 | 670 | 8.479 | 18.978 | 18.014 | 21.524 | 28.958 | 20.654 | 26.360 |
| Employees | - | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - L & L Tabmedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 1.595 | 481 | 524 | 39.880 | 29.423 |
| Current Assets | - | 1.480 | 1.415 | 8.806 | 18.363 | 17.606 | 28.966 | 28.709 | 11.647 | 8.535 |
| Inventories | - | 440 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 252 |
| Receivables | - | 256 | 56 | 55 | 63 | 764 | 164 | 5.428 | 52 | 132 |
| Cash | - | 783 | 1.358 | 8.751 | 18.300 | 16.842 | 28.802 | 23.281 | 11.594 | 8.150 |
| Shareholders Funds | - | 617 | 1.276 | 8.615 | 18.101 | 18.064 | 28.361 | 29.023 | 49.589 | 27.817 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 863 | 138 | 191 | 262 | 1.137 | 1.086 | 210 | 1.938 | 10.141 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - L & L Tabmedica Srl